21. Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. Issue 9 (13th September 2022) Authors: Qu, Xiaoyan; An, Gang; Sui, Weiwei; Wang, Tingyu; Zhang, Xian; Yang, Junfang; Zhang, Yan; Zhang, Lu; Zhu, Dan; Huang, Jiaqi; Zhu, Shigui; Yao, Xin; Li, Jing; Zheng, Chengxiao; Zhu, Kevin; Wei, Yutian; Lv, Xiaoteng; Lan, Liping; Yao, Yihong; Zhou, Daobin Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. Issue 9 (29th July 2019) Authors: Horvath, Noemi; Spencer, Andrew; Kenealy, Melita; Joshua, Douglas; Campbell, Philip J; Lee, Je-Jung; Hou, Jian; Qiu, Lugui; Kalff, Anna; Khong, Tiffany; Londhe, Anil; Siggins, Sarah; van Kooten Losio, Maximiliano; Eisbacher, Michael; Prince, H. Miles Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma. Issue 1 (December 2016) Authors: Leng, Yun; Qiu, Lugui; Hou, Jian; Zhao, Yaozhong; Zhang, Xuejun; Yang, Shifang; Xi, Hao; Huang, Zhongxia; Pan, Ling; Chen, Wenming Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Phase II open‐label study of recombinant circularly permuted TRAIL as a single‐agent treatment for relapsed or refractory multiple myeloma. Issue 1 (8th September 2016) Authors: Leng, Yun; Qiu, Lugui; Hou, Jian; Zhao, Yaozhong; Zhang, Xuejun; Yang, Shifang; Xi, Hao; Huang, Zhongxia; Pan, Ling; Chen, Wenming Journal: Cancer communications Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma. (10th February 2020) Authors: Wu, Xuan; Xia, Jiliang; Zhang, Jingyu; Zhu, Yinghong; Wu, Yangbowen; Guo, Jiaojiao; Chen, Shilian; Lei, Qian; Meng, Bin; Kuang, Chunmei; Feng, Xiangling; He, Yanjuan; Shen, Yi; Li, Xin; Qiu, Lugui; Li, Guancheng; Zhou, Wen Journal: British journal of haematology Issue: Volume 190:Number 1(2020) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Prognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data. Issue 11 (November 2013) Authors: An, Gang; Shi, Lihui; Xu, Yan; Zou, Dehui; Deng, Shuhui; Sui, Weiwei; Zhu, Guoqing; Xie, Zhenqing; Hao, Mu; Sun, Qi; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis. Issue 1 (22nd January 2020) Authors: Yi, Shuhua; Zhang, Yu; Xiong, Wenjie; Chen, Weiwei; Hou, Zhaohua; Yang, Yang; Yan, Yuting; Wei, Yunbo; Cui, Rui; Wang, Huijun; Yu, Zhen; Li, Heng; Li, Zengjun; Liu, Wei; Lv, Rui; Wang, Tingyu; Ru, Kun; Zou, Dehui; Shu, Minglei; Qiu, Lugui Journal: Clinical & translational immunology Issue: Volume 9:Issue 1(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections. Issue 1 (January 2023) Authors: Zhao, Yuanqi; Lin, Qingsong; Zhang, Tingting; Zhen, Sisi; Wang, Jieru; Jiang, Erlie; Mi, Yingchang; Qiu, Lugui; Han, Mingzhe; Wang, Jianxiang; Feng, Sizhou Journal: Journal of infection Issue: Volume 86:Issue 1(2023) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Risk of hepatitis B reactivation is controllable in patients with B‐cell lymphoma receiving anti‐CD19 CAR T cell therapy. (15th July 2020) Authors: Liu, Wei; Huang, Wenyang; Wang, Min; Lv, Rui; Li, Jian; Wang, Ying; Deng, Shuhui; Yi, Shuhua; Liu, Hong; Rao, Qing; Xu, Yingxi; Lv, Lulu; Qiu, Lugui; Zou, Dehui; Wang, Jianxiang Journal: British journal of haematology Issue: Volume 191:Number 1(2020) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial. Issue 1 (January 2019) Authors: Shi, Yuankai; Su, Hang; Song, Yongping; Jiang, Wenqi; Sun, Xiuhua; Qian, Wenbin; Zhang, Wei; Gao, Yuhuan; Jin, Zhengming; Zhou, Jianfeng; Jin, Chuan; Zou, Liqun; Qiu, Lugui; Li, Wei; Yang, Jianmin; Hou, Ming; Zeng, Shan; Zhang, Qingyuan; Hu, Jianda; Zhou, Hui Journal: Lancet Issue: Volume 6:Issue 1(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗